Oct 6 (Reuters) - Australian Pharmaceutical Industries Ltd (API)
- Underlying npat guidance upgraded to $51m - 17% up on prior year
- CEO & MD succession and fy16 forecast update-api.ax
- CEO and Managing Director Stephen Roche to step down in february 2017
- Reported net debt at year end to be less than $30m
- Internal appointee, Richard Vincent to succeed Roche
